Discovery and Structure–Activity Relationships of Pyrrolone Antimalarials

In the pursuit of new antimalarial leads, a phenotypic screening of various commercially sourced compound libraries was undertaken by the World Health Organisation Programme for Research and Training in Tropical Diseases (WHO-TDR). We report here the detailed characterization of one of the hits from this process, TDR32750 (8a), which showed potent activity against Plasmodium falciparum K1 (EC50 ∼ 9 nM), good selectivity (>2000-fold) compared to a mammalian cell line (L6), and significant activity against a rodent model of malaria when administered intraperitoneally. Structure–activity relationship studies have indicated ways in which the molecule could be optimized. This compound represents an exciting start point for a drug discovery program for the development of a novel antimalarial.

[1]  S. Croft,et al.  Artemisone--a highly active antimalarial drug of the artemisinin class. , 2006, Angewandte Chemie.

[2]  T. Kappe,et al.  Benzimidazole condensed ring systems.4. New approaches to the synthesis of substituted pyrimido[1,6-a]-benzimidazole-1,3(2H,5H)-diones , 1989 .

[3]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[4]  P. Olliaro,et al.  The Global Portfolio of New Antimalarial Medicines Under Development , 2009, Clinical pharmacology and therapeutics.

[5]  Chris J Janse,et al.  A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. , 2004, Molecular and biochemical parasitology.

[6]  C. Bevan,et al.  A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.

[7]  G. Allen,et al.  Behavior of 2-halo- and 2-trifluoromethyl-1,4-benzoquinones in the Nenitzescu indole synthesis , 1968 .

[8]  M. Petzold,et al.  Novel Polymorphisms in Plasmodium falciparum ABC Transporter Genes Are Associated with Major ACT Antimalarial Drug Resistance , 2011, PLoS ONE.

[9]  G. Beale,et al.  Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  J. Vorkapić-Furač,et al.  Sterically hindered N-aryl pyrroles: chromatographic separation of enantiomers and barriers to racemization , 1989 .

[11]  A. Cowman,et al.  Chemotherapy and drug resistance in malaria. , 1990, International journal for parasitology.

[12]  Adam R Renslo,et al.  Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.

[13]  D. B. Martins,et al.  Reactivity of chloroacetylated β-enamino compounds. Synthesis of heterocycles , 2002 .

[14]  J. Richard,et al.  Plasmodium Falciparum Malaria Parasite Cultures and Their Use in Immunology , 1990 .

[15]  T. Kappe,et al.  Benzimidazole condensed ring systems. 5. Studies on the Synthesis of Pyrimido[1,6-α]benzimidazole-1,3(2H,5H)-diones† , 1989 .

[16]  M. Abraham,et al.  Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. , 2003, Journal of pharmaceutical sciences.

[17]  R. Obach,et al.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[18]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.